Krystal Biotech, Inc.
KRYS
$306.29
-$10.01-3.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.64% | 9.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.64% | 9.51% | |||
| Cost of Revenue | -4.08% | 54.63% | |||
| Gross Profit | 9.47% | 7.46% | |||
| SG&A Expenses | -1.05% | 10.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.27% | 11.36% | |||
| Operating Income | 21.28% | 7.00% | |||
| Income Before Tax | 20.17% | 6.60% | |||
| Income Tax Expenses | 2,148.33% | 99.14% | |||
| Earnings from Continuing Operations | 8.82% | -35.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.82% | -35.24% | |||
| EBIT | 21.28% | 7.00% | |||
| EBITDA | 20.92% | 7.57% | |||
| EPS Basic | 8.09% | -35.55% | |||
| Normalized Basic EPS | 19.37% | 6.08% | |||
| EPS Diluted | 7.40% | -35.94% | |||
| Normalized Diluted EPS | 19.16% | 5.12% | |||
| Average Basic Shares Outstanding | 0.67% | 0.48% | |||
| Average Diluted Shares Outstanding | 0.85% | 1.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||